American company Johnson & Johnson, the world's largest producer of health products, increased its net profit in the second quarter by 3.1% year-on-year to $3 billion 950 million. Profit without taking into account one-off factors increased by 14.8% to 2 dollars 10 cents per share, the analysts had predicted 2 dollars 7 cents per share. Revenues amounted to 20 billion 800 million dollars, increased by 10.6%. Experts had expected the figure at 20 billion 390 million dollars. In the US, revenue increased by 9.4%, in other countries - by 11.8%. Sales of the pharmaceutical division increased by 19.9%, consumer medical products - by 0.7%.
China’s economy sees quarterly expansion as spending returns14.10.2020
Singapore GDP sees quarterly decline, plunges more than forecasts16.09.2020
Zara's Inditex regains profit after three months due to the coronavirus outbreak19.08.2020
Johnson & Johnson to acquire Momenta over $6.5 billion buyout deal